Dätwyler Stock
Dätwyler Stock price
Key metrics
Is Dätwyler a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.
Dätwyler Stock Analysis
Analyst Opinions
10 Analysts have issued a Dätwyler forecast:
Analyst Opinions
10 Analysts have issued a Dätwyler forecast:
Financial data from Dätwyler
| Jun '25 |
+/-
%
|
||
| Revenue | 1,098 1,098 |
2%
2%
|
|
| Gross Profit | 241 241 |
2%
2%
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | 82 82 |
36%
36%
|
| Net Profit | 30 30 |
59%
59%
|
|
In millions CHF.
Don't miss a Thing! We will send you all news about Dätwyler directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Dätwyler Holding AG engages in the supply of system-critical elastomer components for injectable drug delivery systems. It operates through the Healthcare Solutions and Industrial Solutions segments. The Healthcare Solutions segment offers system-critical components for containers and delivery systems for injectable drugs and diagnostics in the pharmaceutical and medical markets. The Industrial Solutions segment manufactures customized system-critical components for applications in the mobility, food, and beverage, and general industry markets. The company was founded in 1915 and is headquartered in Altdorf, Switzerland.
| Head office | Switzerland |
| CEO | Volker Cwielong |
| Employees | 8,030 |
| Founded | 1915 |
| Website | www.datwyler.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
